TABLE 2.
Study | Number of participants | Symptoms and prevalence (%) |
---|---|---|
(Du et al., 2020) | 85 |
|
(Wang, Yin, et al., 2020) | 107 |
|
(Guan et al., 2020) | 1099 |
|
(Agyeman et al., 2020) (meta‐analysis) |
|
|
Study | Number of participants | Symptoms and prevalence (%) |
---|---|---|
(Du et al., 2020) | 85 |
|
(Wang, Yin, et al., 2020) | 107 |
|
(Guan et al., 2020) | 1099 |
|
(Agyeman et al., 2020) (meta‐analysis) |
|
|